Early Keytruda Results Win Merck An Upgrade
January 16, 2018 at 13:19 PM EST
Merck & Co., Inc. (NYSE: MRK) announcedencouraging dataTuesday from a key study of patients with lung cancer. The ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|